A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.

समान संसाधन

• A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
  द्वारा: Odutola, A, और अन्य
  प्रकाशित: (2012)
• Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
  द्वारा: Ota, M, और अन्य
  प्रकाशित: (2011)
• Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
  द्वारा: Ota, M, और अन्य
  प्रकाशित: (2011)
• Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
  द्वारा: Owiafe, P, और अन्य
  प्रकाशित: (2012)
• The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
  द्वारा: Tameris, M, और अन्य
  प्रकाशित: (2014)